DD80967A - - Google Patents
Info
- Publication number
- DD80967A DD80967A DD80967DA DD80967A DD 80967 A DD80967 A DD 80967A DD 80967D A DD80967D A DD 80967DA DD 80967 A DD80967 A DD 80967A
- Authority
- DD
- German Democratic Republic
Links
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD80967A true DD80967A (pt) |
Family
ID=267392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD80967D DD80967A (pt) |
Country Status (1)
| Country | Link |
|---|---|
| DD (1) | DD80967A (pt) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2574334A1 (en) | 2005-01-14 | 2013-04-03 | Cephalon, Inc. | Bendamustine pharmaceutical compositions for lyophilisation |
| US20130217888A1 (en) * | 2010-11-01 | 2013-08-22 | Shailpa Medicare Limited | Process for preparing bendamus tine hydrochloride monohydrate |
| US8669279B2 (en) | 2008-03-26 | 2014-03-11 | Cephalon, Inc. | Solid forms of bendamustine hydrochloride |
-
0
- DD DD80967D patent/DD80967A/xx unknown
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2574334A1 (en) | 2005-01-14 | 2013-04-03 | Cephalon, Inc. | Bendamustine pharmaceutical compositions for lyophilisation |
| US8791270B2 (en) | 2005-01-14 | 2014-07-29 | Cephalon, Inc. | Bendamustine pharmaceutical compositions |
| US8895756B2 (en) | 2005-01-14 | 2014-11-25 | Cephalon, Inc. | Bendamustine pharmaceutical compositions |
| US8669279B2 (en) | 2008-03-26 | 2014-03-11 | Cephalon, Inc. | Solid forms of bendamustine hydrochloride |
| US8883836B2 (en) | 2008-03-26 | 2014-11-11 | Cephalon, Inc. | Solid forms of bendamustine hydrochloride |
| US9533955B2 (en) | 2008-03-26 | 2017-01-03 | Cephalon, Inc. | Solid forms of bendamustine hydrochloride |
| US10039750B2 (en) | 2008-03-26 | 2018-08-07 | Cephalon, Inc. | Solid forms of bendamustine hydrochloride |
| US20130217888A1 (en) * | 2010-11-01 | 2013-08-22 | Shailpa Medicare Limited | Process for preparing bendamus tine hydrochloride monohydrate |
| US20150175554A1 (en) * | 2010-11-01 | 2015-06-25 | Shilpa Medicare Limited | Highly pure bendamustine hydrochloride monohydrate |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5726833B2 (ja) | ベンダムスチン製薬学的組成物 | |
| CA2149329C (en) | Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma | |
| EP2271315B1 (en) | Solid forms of bendamustine hydrochloride | |
| CA2215329C (en) | Colorectal chemoprotective composition and method for preventing colorectal cancer | |
| US20170189382A1 (en) | Compounds for treating brain cancer | |
| JP2008526991A5 (pt) | ||
| US20150175554A1 (en) | Highly pure bendamustine hydrochloride monohydrate | |
| WO2009048698A9 (en) | Co-solvent compositions and methods for improved delivery of dantrolene therapeutic agents | |
| EP2958554B1 (en) | Stable compositions of bendamustine | |
| EP2667868A2 (en) | Bendamustine formulations | |
| US10294208B2 (en) | Bendamustine derivatives and related compounds, and medical use thereof in cancer therapy | |
| TWI690514B (zh) | 一種鹽酸苯達莫司汀的晶體及其製備方法 | |
| US20110217258A1 (en) | Combined Use of Bendamustine, Doxorubicin and Bortezomib for the Treatment of Multiple Myeloma |